ReP USP - Resultado da busca

Artigo de periodico
CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy (2020)
Genvigir, Fabiana Dalla Vecchia; Campos-Salazar, Antony Brayan ; Felipe, Claudia Rosso ; Silva Junior, Helio Tedesco ; Pestana, José Osmar Medina ; Doi, Sonia de Quateli; Cerda, Alvaro; Hirata, Mario Hiroyuki ; Herrero, María José; Hirata, Rosario Dominguez Crespo
Source: Pharmacogenomics. Unidade: FCF
Subjects: TRANSPLANTE DE RIM, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GENVIGIR, Fabiana Dalla Vecchia et al. CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy. Pharmacogenomics, v. 21, n. 1, p. 7-21, 2020Tradução . . Disponível em: https://doi.org/10.2217/pgs-2019-0120. Acesso em: 17 nov. 2024.
APA
Genvigir, F. D. V., Campos-Salazar, A. B., Felipe, C. R., Silva Junior, H. T., Pestana, J. O. M., Doi, S. de Q., et al. (2020). CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy. Pharmacogenomics, 21( 1), 7-21. doi:10.2217/pgs-2019-0120
NLM
Genvigir FDV, Campos-Salazar AB, Felipe CR, Silva Junior HT, Pestana JOM, Doi S de Q, Cerda A, Hirata MH, Herrero MJ, Hirata RDC. CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy [Internet]. Pharmacogenomics. 2020 ; 21( 1): 7-21.[citado 2024 nov. 17 ] Available from: https://doi.org/10.2217/pgs-2019-0120
Vancouver
Genvigir FDV, Campos-Salazar AB, Felipe CR, Silva Junior HT, Pestana JOM, Doi S de Q, Cerda A, Hirata MH, Herrero MJ, Hirata RDC. CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy [Internet]. Pharmacogenomics. 2020 ; 21( 1): 7-21.[citado 2024 nov. 17 ] Available from: https://doi.org/10.2217/pgs-2019-0120
Artigo de periodico
Mycophenolic acid pharmacogenomics in kidney transplantation (2020)
Genvigir, Fabiana Dalla Vecchia; Cerda, Alvaro ; Hirata, Thiago Dominguez Crespo ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Journal of Translational Genetics and Genomics. Unidade: FCF
Subjects: TRANSPLANTE DE RIM, FÁRMACOS IMUNOSSUPRESSORES, FARMACODINÂMICA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GENVIGIR, Fabiana Dalla Vecchia et al. Mycophenolic acid pharmacogenomics in kidney transplantation. Journal of Translational Genetics and Genomics, v. 4, p. 320-55, 2020Tradução . . Disponível em: https://doi.org/10.20517/jtgg.2020.37. Acesso em: 17 nov. 2024.
APA
Genvigir, F. D. V., Cerda, A., Hirata, T. D. C., Hirata, M. H., & Hirata, R. D. C. (2020). Mycophenolic acid pharmacogenomics in kidney transplantation. Journal of Translational Genetics and Genomics, 4, 320-55. doi:10.20517/jtgg.2020.37
NLM
Genvigir FDV, Cerda A, Hirata TDC, Hirata MH, Hirata RDC. Mycophenolic acid pharmacogenomics in kidney transplantation [Internet]. Journal of Translational Genetics and Genomics. 2020 ; 4 320-55.[citado 2024 nov. 17 ] Available from: https://doi.org/10.20517/jtgg.2020.37
Vancouver
Genvigir FDV, Cerda A, Hirata TDC, Hirata MH, Hirata RDC. Mycophenolic acid pharmacogenomics in kidney transplantation [Internet]. Journal of Translational Genetics and Genomics. 2020 ; 4 320-55.[citado 2024 nov. 17 ] Available from: https://doi.org/10.20517/jtgg.2020.37
Artigo de periodico
Genetic susceptibility in pharmacodynamic and pharmacokinetic pathways underlying drug-induced arrhythmia and sudden unexplained deaths (2019)
Matilla, Marina Martinez; Verea, Alejandro J. Blanco; Santori, Montserrat; Bermejo, Juan Ansede; Luis, Eva Ramos; Gil, Rocio; Bermejo, Ana María; Lotufo Neto, Francisco; Hirata, Mario Hiroyuki ; Brisighelli, Francesca; Páramo, Mario; Carracedo, Ángel M; Brion, Maria
Source: Forensic Science International. Unidades: FM, FCF
Subjects: FARMACOCINÉTICA, FARMACODINÂMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATILLA, Marina Martinez et al. Genetic susceptibility in pharmacodynamic and pharmacokinetic pathways underlying drug-induced arrhythmia and sudden unexplained deaths. Forensic Science International, v. 42, p. 203-212, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.fsigen.2019.07.010. Acesso em: 17 nov. 2024.
APA
Matilla, M. M., Verea, A. J. B., Santori, M., Bermejo, J. A., Luis, E. R., Gil, R., et al. (2019). Genetic susceptibility in pharmacodynamic and pharmacokinetic pathways underlying drug-induced arrhythmia and sudden unexplained deaths. Forensic Science International, 42, 203-212. doi:10.1016/j.fsigen.2019.07.010
NLM
Matilla MM, Verea AJB, Santori M, Bermejo JA, Luis ER, Gil R, Bermejo AM, Lotufo Neto F, Hirata MH, Brisighelli F, Páramo M, Carracedo ÁM, Brion M. Genetic susceptibility in pharmacodynamic and pharmacokinetic pathways underlying drug-induced arrhythmia and sudden unexplained deaths [Internet]. Forensic Science International. 2019 ; 42 203-212.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.fsigen.2019.07.010
Vancouver
Matilla MM, Verea AJB, Santori M, Bermejo JA, Luis ER, Gil R, Bermejo AM, Lotufo Neto F, Hirata MH, Brisighelli F, Páramo M, Carracedo ÁM, Brion M. Genetic susceptibility in pharmacodynamic and pharmacokinetic pathways underlying drug-induced arrhythmia and sudden unexplained deaths [Internet]. Forensic Science International. 2019 ; 42 203-212.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.fsigen.2019.07.010
Artigo de periodico
Influence of SLCO1B1 and SLCO2B1 polymorphisms on tacrolimus pharmacokinetics and clinical response (2014)
Alves, Camila; Felipe, Claudia Rosso; Nishikawa, Alvaro Mitsunori; Salgado, Patricia de Cássia; Fajardo, Cristina Moreno ; Silva Junior, Helio Tedesco; Pestana, Jose Osmar Medina; Zetchaku, Denize; Spinelli, Glaucio; Oliveira, Nagilla; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo ; Rodrigues, Alice Cristina
Source: Journal Pharmacogenomics Pharmacoproteomics. Unidades: FCF, ICB
Subjects: POLIMORFISMO, FARMACOCINÉTICA, TRANSPLANTE DE RIM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVES, Camila et al. Influence of SLCO1B1 and SLCO2B1 polymorphisms on tacrolimus pharmacokinetics and clinical response. Journal Pharmacogenomics Pharmacoproteomics, v. 5, n. 3, p. 1-16 art. 1000134, 2014Tradução . . Disponível em: https://doi.org/10.4172/2153-0645.1000134. Acesso em: 17 nov. 2024.
APA
Alves, C., Felipe, C. R., Nishikawa, A. M., Salgado, P. de C., Fajardo, C. M., Silva Junior, H. T., et al. (2014). Influence of SLCO1B1 and SLCO2B1 polymorphisms on tacrolimus pharmacokinetics and clinical response. Journal Pharmacogenomics Pharmacoproteomics, 5( 3), 1-16 art. 1000134. doi:10.4172/2153-0645.1000134
NLM
Alves C, Felipe CR, Nishikawa AM, Salgado P de C, Fajardo CM, Silva Junior HT, Pestana JOM, Zetchaku D, Spinelli G, Oliveira N, Hirata MH, Hirata RDC, Rodrigues AC. Influence of SLCO1B1 and SLCO2B1 polymorphisms on tacrolimus pharmacokinetics and clinical response [Internet]. Journal Pharmacogenomics Pharmacoproteomics. 2014 ; 5( 3): 1-16 art. 1000134.[citado 2024 nov. 17 ] Available from: https://doi.org/10.4172/2153-0645.1000134
Vancouver
Alves C, Felipe CR, Nishikawa AM, Salgado P de C, Fajardo CM, Silva Junior HT, Pestana JOM, Zetchaku D, Spinelli G, Oliveira N, Hirata MH, Hirata RDC, Rodrigues AC. Influence of SLCO1B1 and SLCO2B1 polymorphisms on tacrolimus pharmacokinetics and clinical response [Internet]. Journal Pharmacogenomics Pharmacoproteomics. 2014 ; 5( 3): 1-16 art. 1000134.[citado 2024 nov. 17 ] Available from: https://doi.org/10.4172/2153-0645.1000134

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration